Dialysis patients' symptoms often ignored – new trial aims to change that

NCT ID NCT06257134

Recruiting now Symptom relief Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether having dialysis patients report their symptoms every month – and automatically alerting their care team when symptoms are severe – can improve their quality of life. About 2,293 adults with end-stage kidney disease on dialysis will take part across French centers. Half will get usual care, and half will have their symptom scores sent to staff so they can act quickly. The goal is to see if this simple monitoring helps patients feel better physically and mentally over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: systematic symptom monitoring with feedback to healthcare teams
What this could lead to: If it works, this could give dialysis patients a better quality of life by helping doctors catch and treat symptoms sooner.
What could go wrong: This is a large trial, but it's testing a monitoring process, not a new drug. The benefit may be small or hard to measure, and results may not apply to all dialysis centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END-STAGE RENAL DISEASE

Contacts and locations

Locations

ALTIR
RECRUITING

Vandœuvre-lès-Nancy, 54 500, France
CHRU Nancy
RECRUITING

Vandœuvre-lès-Nancy, 54500, France
Maison du Rein AURAD Aquitaine
NOT_YET_RECRUITING

Gradignan, 33171, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.